This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merz Pharma Gmbh & Co. Kgaa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Radovan Vukicevic and His Work on Modified Hyaluronic Acid
Introduction
Radovan Vukicevic is an inventor associated with Frankfurt am Main, Germany, and Merz Pharma GmbH & Co. KGaA. His patent work concerns a modified hyaluronic acid derivative intended for preparing crosslinked hydrogels for aesthetic applications.
Latest Patents
Vukicevic is associated with 1 patent: “Aldehyde-modified hyaluronic acid, method for preparing same and applications thereof.” The invention describes modifying the —CH₂-OH group of the N-acetyl-D-glucosamine unit in hyaluronic acid to an aldehyde group with the structure —CH₂-O—CH₂—CHO. The degree of modification ranges from 1.0% to 15.0%.
The patent also describes preparing the derivative by reacting glycerol-modified hyaluronic acid with an oxidizing agent, such as periodate. The resulting material is intended for forming a crosslinked hydrogel for aesthetic applications.
Career Highlights
The available information connects Vukicevic’s patent activity with Merz Pharma GmbH & Co. KGaA. His listed invention focuses on chemical modification and preparation methods for hyaluronic acid materials.
Collaborations
Patrick Plitt and Colin Drabe are identified as Vukicevic’s coworkers. The provided information does not specify their roles in the patent or the invention.
Conclusion
Radovan Vukicevic’s listed patent describes an aldehyde-modified hyaluronic acid derivative and a preparation method aimed at crosslinked hydrogels for aesthetic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile